BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 28637621)

  • 21. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
    Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
    J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
    West RR; Hsu AP; Holland SM; Cuellar-Rodriguez J; Hickstein DD
    Haematologica; 2014 Feb; 99(2):276-81. PubMed ID: 24077845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
    Shimizu R; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency.
    Ellingford JM; Telford N; Urquhart J; Will AM; Bonney D; Adams B; Dixon R; Kerr B; Black GC; Wynn RF; Meyer S
    Cancer Genet; 2021 Aug; 256-257():77-80. PubMed ID: 33957466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS.
    Saida S; Umeda K; Yasumi T; Matsumoto A; Kato I; Hiramatsu H; Ohara O; Heike T; Adachi S
    Pediatr Transplant; 2016 Mar; 20(2):333-6. PubMed ID: 26748574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline GATA2 Mutation and Bone Marrow Failure.
    McReynolds LJ; Calvo KR; Holland SM
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
    Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
    Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [GATA2 gene mutations: 3 cases].
    Perrard N; Pokeerbux MR; Quesnel B; Duployez N; Fenwarth L; Preudhomme C; Lefèvre G; Baillet C; Launay D; Terriou L
    Rev Med Interne; 2022 Nov; 43(11):677-682. PubMed ID: 36041908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.
    Maciejewski-Duval A; Meuris F; Bignon A; Aknin ML; Balabanian K; Faivre L; Pasquet M; Barlogis V; Fieschi C; Bellanné-Chantelot C; Donadieu J; Schlecht-Louf G; Marin-Esteban V; Bachelerie F
    J Leukoc Biol; 2016 Jun; 99(6):1065-76. PubMed ID: 26710799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding.
    Hasegawa A; Hayasaka Y; Morita M; Takenaka Y; Hosaka Y; Hirano I; Yamamoto M; Shimizu R
    Commun Biol; 2022 Apr; 5(1):376. PubMed ID: 35440757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATA 2 Deficiency: Focus on Immune System Impairment.
    Fabozzi F; Mastronuzzi A; Ceglie G; Masetti R; Leardini D
    Front Immunol; 2022; 13():865773. PubMed ID: 35769478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic mutations in children with
    Fisher KE; Hsu AP; Williams CL; Sayeed H; Merritt BY; Elghetany MT; Holland SM; Bertuch AA; Gramatges MM
    Blood Adv; 2017 Feb; 1(7):443-448. PubMed ID: 29296959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
    Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
    Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.